About
Saccharo, Inc is a preclinical stage oncology company developing cancer therapies that target a novel polysaccharide-based immune shielding pathway to treat solid tumors and hematologic cancers.
Explore Saccharo, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.